The Video-On-Demand has been expired. If you would like to view any sessions related to WCN 2023, please don't hesitate to contact infowcn@theisn.org.
 

Risks and Management of AKI Biomarkers

1 Apr 2023 14:15 15:15
Plenary Hall 1
Somchai Eiam Ong Chairperson Chulalongkorn Memorial Hospital Thailand
Dibya Singh Shah Chairperson Institute of Medicine ,Tribhuvan University Teaching HospitalNepal

Session Description:
This session aims to cover a number of very important aspects relating to the acute kidney injury (AKI) Biomarkers. Implement biomarkers in the clinical workflow to improve AKI and RRT care session will demonstrate how to apply novel AKI biomarkers in AKI clinical practice from prediction persistent AKI, AKI outcome, and guiding renal replacement therapy initiation. Urinary sediments in AKI session will describe and discuss the value of utilizing urine microscopy in the diagnosis of AKI. Finally, there will be an update in novel biomarkers in AKI which has been recently discovered.

Learning Objectives:
An application for AKI biomarkers in clinical practice. A utilization urine microscopy in the management of AKI. An update on current and recent discovered AKI biomarkers.

Time Session
14:15
14:30
Nattachai Srisawat Speaker drnattachai@yahoo.comChulalongkorn University, King Chulalongkorn Memorial HospitalThailand
14:30
14:45
Xizi Zheng Speaker Peking University First HospitalChina
14:45
15:00
Chirag Parikh Speaker chirag.parikh@jhmi.eduJohns Hopkins UniversityUnited States
15:00
15:15